436 related articles for article (PubMed ID: 15948978)
21. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
[TBL] [Abstract][Full Text] [Related]
22. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
23. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
[TBL] [Abstract][Full Text] [Related]
24. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
[TBL] [Abstract][Full Text] [Related]
25. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils.
Shinkai A; Yoshisue H; Koike M; Shoji E; Nakagawa S; Saito A; Takeda T; Imabeppu S; Kato Y; Hanai N; Anazawa H; Kuga T; Nishi T
J Immunol; 1999 Aug; 163(3):1602-10. PubMed ID: 10415065
[TBL] [Abstract][Full Text] [Related]
26. Chemokines induce eosinophil degranulation through CCR-3.
Fujisawa T; Kato Y; Nagase H; Atsuta J; Terada A; Iguchi K; Kamiya H; Morita Y; Kitaura M; Kawasaki H; Yoshie O; Hirai K
J Allergy Clin Immunol; 2000 Sep; 106(3):507-13. PubMed ID: 10984371
[TBL] [Abstract][Full Text] [Related]
27. Mast cells and T cells in Kimura's disease express increased levels of interleukin-4, interleukin-5, eotaxin and RANTES.
Kimura Y; Pawankar R; Aoki M; Niimi Y; Kawana S
Clin Exp Allergy; 2002 Dec; 32(12):1787-93. PubMed ID: 12653173
[TBL] [Abstract][Full Text] [Related]
28. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.
Simon D; Vassina E; Yousefi S; Kozlowski E; Braathen LR; Simon HU
J Allergy Clin Immunol; 2004 Oct; 114(4):887-95. PubMed ID: 15480330
[TBL] [Abstract][Full Text] [Related]
29. Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts.
Nonaka M; Pawankar R; Fukumoto A; Ogihara N; Sakanushi A; Yagi T
Clin Exp Allergy; 2004 May; 34(5):804-11. PubMed ID: 15144475
[TBL] [Abstract][Full Text] [Related]
30. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
31. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
Furukawa H; Nakamura K; Zheng X; Tojo M; Oyama N; Akiba H; Nishibu A; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
J Dermatol Sci; 2004 Jun; 35(1):35-42. PubMed ID: 15194145
[TBL] [Abstract][Full Text] [Related]
32. Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans.
Menzies-Gow A; Ying S; Phipps S; Kay AB
Clin Exp Allergy; 2004 Aug; 34(8):1276-82. PubMed ID: 15298570
[TBL] [Abstract][Full Text] [Related]
33. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis.
Taha RA; Minshall EM; Leung DY; Boguniewicz M; Luster A; Muro S; Toda M; Hamid QA
J Allergy Clin Immunol; 2000 May; 105(5):1002-7. PubMed ID: 10808183
[TBL] [Abstract][Full Text] [Related]
34. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
Shahabuddin S; Ponath P; Schleimer RP
J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
[TBL] [Abstract][Full Text] [Related]
35. Role of the chemokine eotaxin in the pathogenesis of equine sweet itch.
Benarafa C; Collins ME; Hamblin AS; Cunningham FM
Vet Rec; 2002 Dec; 151(23):691-3. PubMed ID: 12503787
[TBL] [Abstract][Full Text] [Related]
36. The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts.
Puxeddu I; Bader R; Piliponsky AM; Reich R; Levi-Schaffer F; Berkman N
J Allergy Clin Immunol; 2006 Jan; 117(1):103-10. PubMed ID: 16387592
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions.
Yawalkar N; Shrikhande M; Hari Y; Nievergelt H; Braathen LR; Pichler WJ
J Allergy Clin Immunol; 2000 Dec; 106(6):1171-6. PubMed ID: 11112902
[TBL] [Abstract][Full Text] [Related]
38. [Dysregulation of cooperative interactions of immunocytes and eosinophils in the mechanism of development of eosinophilia in Opisthorhis felineus invasion].
Litvinova LS; Riazantseva NV; Novitskiĭ VV
Med Parazitol (Mosk); 2008; (3):13-7. PubMed ID: 18819423
[TBL] [Abstract][Full Text] [Related]
39. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
[TBL] [Abstract][Full Text] [Related]
40. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.
Yoshifuku K; Matsune S; Ohori J; Sagara Y; Fukuiwa T; Kurono Y
Rhinology; 2007 Sep; 45(3):235-41. PubMed ID: 17956026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]